Literature DB >> 6364879

Nifedipine--a calcium channel blocker--in asthmatic patients. Interaction with terbutaline.

K Svedmyr, C G Löfdahl, N Svedmyr.   

Abstract

Seven asthmatic patients were studied in a single-blind randomized, crossover study after oral administration of 20 mg nifedipine or placebo. Four increasing doses of i.v. terbutaline were then given with 30 min interval. The study was concluded with inhalation of five terbutaline puffs. FEV1 measurements 30 min after intake of nifedipine did not show any difference compared to placebo. During the terbutaline treatment, however, there was a more pronounced bronchodilation after nifedipine than after placebo (P less than 0.05). Terbutaline-induced skeletal muscle tremor was similar after nifedipine and placebo pretreatments. After nifedipine intake there was a decrease of diastolic blood pressure and a reflexogenic tachycardia. Thus, this study showed a small potentiation of the beta 2-adrenoceptor mediated bronchodilation, which is of importance when treating patients with simultaneous asthma and hypertension or angina pectoris.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6364879     DOI: 10.1111/j.1398-9995.1984.tb01928.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  8 in total

1.  Efficacy of calcium channel blockers as maintenance therapy for asthma.

Authors:  Mary Ann Twiss; Eloise Harman; Sarah Chesrown; Leslie Hendeles
Journal:  Br J Clin Pharmacol       Date:  2002-03       Impact factor: 4.335

Review 2.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 3.  Calcium antagonists--adverse drug interactions.

Authors:  H Reicher-Reiss; H N Neufeld; F X Ebner
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

Review 4.  Heterogeneity of calcium channels in mast cells and basophils and the possible relevance to pathophysiology of lung diseases: a review.

Authors:  N Chand; J L Perhach; W Diamantis; R D Sofia
Journal:  Agents Actions       Date:  1986-03

Review 5.  Clinical studies with calcium antagonists in asthma.

Authors:  P J Barnes
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

6.  Effect of nifedipine on serum theophylline concentrations and asthma control.

Authors:  S R Smith; J Wiggins; D E Stableforth; C Skinner; M J Kendall
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

Review 7.  Anaesthetic implications of calcium channel blockers.

Authors:  L C Jenkins; P J Scoates
Journal:  Can Anaesth Soc J       Date:  1985-07

8.  Verapamil in the prophylaxis of bronchial asthma. Is the bronchoprotective effect related to the plasma level?

Authors:  E Imhof; S Elsasser; B Rosmus; H R Ha; F Follath; A P Perruchoud
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.